[Management of keratoconjunctivitis sicca using bromhexine-containing eye drops and bromhexine capsules].
D000814:Aniline Compounds / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D004338:Drug Combinations; D005094:Exophthalmos / Q000150:complications; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy*; D008722:Methods; D009883:Ophthalmic Solutions; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000188:drug therapy; D013607:Tablets
D000814:Aniline Compounds; D001593:Benzyl Compounds; D003510:Cyclohexanes; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D000644:Quaternary Ammonium Compounds; D013607:Tablets
Behandlung der Keratoconjunctivitis sicca mit bromhexinhaltigen Augentropfen und Bromhexine-Kpapseln.